Sri Lanka Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2013 Jul 10th 2013, 00:00, by rnrmahesh BMI View: Increased longevity in developed markets translates into increased demand for healthcare services and medicines for the elderly. However, in emerging markets such as Sri Lanka, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades. This will continue to limit revenue-earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases. Headline Expenditure Projections ? Pharmaceuticals: LKR59.86bn (US$469mn) in 2012 to LKR67.69bn (US$535mn) in 2013; +13.1% in local currency terms and +14.0% in US dollar terms. ? Healthcare: LKR252.37bn (US$1.98bn) in 2012 to LKR280.94bn (US$2.22bn) in 2013; … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=106037. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/sri-lanka-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions